Page 964 - Williams Hematology ( PDFDrive )
P. 964

939




                  CHAPTER 61                                                 DEFINITION AND HISTORY

                  PRODUCTION,                                           Neutrophils are produced in the marrow, where they arise from progen-
                                                                        itor and precursor cells by a process of cellular proliferation and matu-
                                                                                                                   1,2
                  DISTRIBUTION, AND                                     ration. They differentiate from the pluripotential stem cell  through a
                                                                        series of progressively more committed progenitor or colony-forming
                                                                        units, including the granulocyte-monocyte colony-forming unit and the
                  FATE OF NEUTROPHILS                                   granulocyte colony-forming unit, which give rise to neutrophils.  The
                                                                                                                       3,4
                                                                        early progenitor cells cannot be recognized under the microscope
                                                                        but can be identified retrospectively by the type of colony formed in
                                                                        culture of marrow cells (Chap. 18). The earliest morphologically recog-
                  C. Wayne Smith                                        nizable neutrophil precursor is the myeloblast. From there, the formal
                                                                        sequence of precursor development is myeloblast → promyelocyte →
                                                                        myelocyte → metamyelocyte → band neutrophil → segmented neu-
                    SUMMARY                                             trophil (Chap. 60). The term granulocyte often is loosely used to refer
                                                                        to neutrophils but strictly speaking includes eosinophils and basophils.
                    Blood neutrophil levels are maintained in a normal steady state by   Eosinophilic (Chap. 62) and basophilic granulocytes (Chap. 63) develop
                    hematopoiesis in the marrow, the distribution of neutrophils between   from progenitors in a manner analogous to the neutrophils, although
                    the marginated pool in the microvasculature and the freely circulating   commitment to neutrophilic, eosinophilic, or basophilic development
                    pool in the blood, and the rate of egress from blood to tissues. Marrow   probably is established at an early progenitor stage, and are dependent
                                                                        on the cytokines interleukin (IL)-5 and stem cell factor, respectively.
                    production of neutrophils is regulated by three principal glycoprotein   The normal human neutrophil production rate is 0.85 to 1.6 × 10
                                                                                                                           9
                    hormones, or cytokines: interleukin-3, granulocyte-monocyte colony-  cells/kg per day. Mature neutrophils are stored in the marrow before
                    stimulating factor, and granulocyte colony-stimulating factor (G-CSF),   they are released into the blood. In the absence of an inflammatory
                    but  only  the  genetic  elimination  of  G-CSF  has  a  measurable  effect  on   focus, they leave the circulation randomly, with a half-disappearance
                    blood neutrophil levels. The latter two cytokines are available as recom-  time of approximately 7 hours. The cells then enter the tissues and prob-
                    binant pharmaceutical products that can be administered therapeutically   ably function for 1 or 2 days before their death or loss into the gastroin-
                    to ameliorate certain causes of neutropenia. Neutrophil interaction with   testinal tract through mucosal surfaces.
                    endothelium  is  mediated  by  selectins,  glycoproteins  with  sugar-bind-  The marrow has an impressive capacity to produce neutrophils,
                    ing sites that support shear-dependent rolling on endothelium, and by   yet it is carefully regulated both at steady state and in times of height-
                    integrins on the neutrophil binding to ligands on the endothelial cells,   ened demand. This chapter outlines current concepts of neutrophil pro-
                    permitting firm attachment to endothelium and emigration into tissues.   duction, distribution, and survival. For detailed data and methods, the
                                                                        reader is referred to original articles and reviews on neutropoiesis and
                    Neutrophils have a short life span in blood, with a disappearance half-  neutrophil kinetics. 5–17
                    time of approximately 7 hours.  The process can be accelerated when
                    inflammation is present and highlights the need for a sustained rate of
                    production to maintain a normal blood neutrophil count. The pathogen-    REGULATION OF NEUTROPHILIC
                    esis of neutropenia is more complex to analyze kinetically than anemia   GRANULOPOIESIS
                    or thrombocytopenia because at least four compartments are involved:
                    marrow storage pool, circulating pool, marginated pool, and tissue pool.   Although  the  primary  cellular  manifestation  of  commitment  is  the
                    The latter is particularly difficult to assay. Measurements can be further   expression of receptors for lineage-specific hematopoietic growth fac-
                    complicated in the nonsteady state, when dramatic increases in turnover   tors, the “decision” for a stem cell to self-renew is, at least partially, a
                                                                                    1,18
                    rates and distribution among the four principal pools are in disequilib-  stochastic event.  On the other hand, stromal elements, collectively
                    rium, as occurs during acute inflammatory states.   referred to as the hematopoietic microenvironment, release short-range
                                                                        signals that regulate the process of commitment from multipotential
                                                                        stem cell pools. Although many details of hematopoietic stem cell reg-
                                                                        ulation (Chap. 18) remain to be elucidated, much is known regarding
                                                                        the interaction of hematopoietic cytokines with their  receptors  and
                                                                        actions on the committed granulocyte progenitor cells and their mature
                                                                        progeny. 19–24
                    Acronyms and Abbreviations: β -Integrin, a member of family of recep-
                                             2
                    tors that mediate attachment between a cell and the tissues surrounding it; C5a,
                    chemotactic fragment of complement component C5; CD, one of the cluster of dif-  HUMORAL REGULATORS
                    ferentiation antigens; CSF, colony-stimulating factor; DF P, diisopropyl fluorophos-  The humoral regulators involved in granulopoiesis have been
                                                   32
                    phate; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-monocyte   defined by in vitro culture systems. 20,21  Originally identified by their
                    colony-stimulating factor; IL, interleukin; L-selectin (and other selectins), a member   ability to stimulate colony formation from marrow progenitor cells,
                    of selectin family of proteins, which are leukocyte cell-adhesion molecules; Mr, rela-  the hemopoietic cytokines were initially termed colony-stimulating
                    tive molecular mass; NTR, neutrophil turnover rate; T , half-time; TBNP, total blood   factors (CSFs) based on this assay system.  With regard to neu-
                                                                                                          25
                                                 1/2
                    neutrophil pool; TNF-α, tumor necrosis factor-α.    trophil production, at least four human CSFs have been defined.
                                                                        Granulocyte-monocyte colony-stimulating  factor (GM-CSF)  is a








          Kaushansky_chapter 61_p0939-0946.indd   939                                                                   9/18/15   9:41 AM
   959   960   961   962   963   964   965   966   967   968   969